Find News

Filter articles

Applied Filters

Showing 1 to 10 of 208 results

Insilico Medicine signs $200m AI drug discovery deal

10-10-2019Rory O'Neill

Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company.

US biotech licenses antibody from Takeda for new kidney drugs

Japan, US04-10-2019Rory O'Neill

Goldfinch Bio, a US company focused on developing treatments for kidney disease, has agreed to license a cannabinoid receptor 1 antibody from Japanese pharmaceutical manufacturer Takeda.

Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech

Taiwan, US30-09-2019Sarah Morgan

Taiwan-based Personal Genomics Taiwan has taken gene-sequencing rival Pacific Biosciences to court in the US, over alleged patent infringement.

Taiwanese biotech abandons drug R&D under Genentech MoU

Taiwan, US10-09-2019Sarah Morgan

Taiwanese company JHL Biotech will stop developing biosimilar versions of Genentech’s drugs as part of a memorandum of understanding signed by the parties to end trade secrets litigation.

Lupin and Boehringer enter $720m anti-cancer drug partnership

Germany, India05-09-2019Sarah Morgan

Indian drugmaker Lupin and German pharma company Boehringer Ingelheim have formed an alliance to develop a therapy for patients with difficult-to-treat cancers.

Counterfeit HPV vaccines seized in Hong Kong

Hong Kong18-07-2019Rory O'Neill

Hong Kong customs authorities have carried out a series of raids resulting in the seizure of counterfeit vaccines worth over HKD $1 million, some containing poison.

Pepsi drops litigation against Indian farmers


PepsiCo India is withdrawing its lawsuits against nine farmers in the Gujarat region who it accused of growing a protected variety of potato used to make the company’s ‘Lay’s’ brand of crisps.

Pepsi offers to settle Indian potato dispute amid criticism


PepsiCo India is attempting to settle a lawsuit against four Indian farmers who the food and drink company say infringed its IP by growing a protected variety of potato.

Duane Morris hires Winston & Strawn lawyer

Taiwan, US10-04-2019

Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.

WHO to begin working on gene editing research registry


World Health Organization (WHO) experts have called for central registry on human genome editing research is needed, among a committee consensus that it would be irresponsible for any scientist to conduct gene-editing studies in people.

Showing 1 to 10 of 208 results